Skip to main content

A child sits with his mother

Two families reflect on their malaria vaccine journey

Catching up with the first children to receive the RTS,S malaria vaccine in Malawi, one year later.

Kenya strengthens fight against malaria with new vaccine

The world's first malaria vaccine is now available in certain areas of Kenya, offering an additional way to protect young children from this disease, which is a top 10 cause of illness and death, and a leading killer of children under the age of five....

GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine

Bharat Biotech will produce the antigen for RTS,S/AS01 following technology transfer. Read more

We’re ready to beat malaria. Are you?

Put your knowledge to the test with a three-question quiz. Ready to begin?

Home

Latest

GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine

Frequently Asked Questions (FAQs): Product Transfer for the RTS,S/AS01 Malaria Vaccine

Milestone study identifies immune markers that may help predict success of vaccination with RTS,S/AS01 malaria vaccine

PATH receives new five-year contract from USAID for malaria vaccine research and development

A child sits with his mother

Two families reflect on their malaria vaccine journey

PATH continues exciting partnership with the GHIT Fund to develop a next-generation malaria vaccine

Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to Plasmodium falciparum circumsporozoite protein

Journal article

RTS,S Malaria Vaccine: 2019 Partnership Award Honoree

PATH and partners receive award for development of world’s first malaria vaccine

RTS,S malaria vaccine frequently asked questions (FAQs)

The RTS,S malaria vaccine

Pictured here with his mother, Elian Koech was the first child to receive the vaccine in Kenya.

Kenya joins Malawi and Ghana to roll out the world’s first malaria vaccine

Twitter @MalariaVaccine

RT @malarianomoreuk: Continued innovation is needed to ensure we continue to have effective, inexpensive and efficient tools to achieve… https://t.co/aC8EkKcYAI

29 Jul 2021

RT @WHOAFRO: Each year, #malaria claims 400,000+ lives in #Africa. @BioNTech_Group’s mRNA-based vaccine initiative is a huge o… https://t.co/GGePycbdK4

28 Jul 2021

RT @MSuzman: We take one step closer to a malaria-free world with this exciting new project that seeks to develop an mRNA-based… https://t.co/4TPEUPVHw3

27 Jul 2021

RT @MiM_Melbourne: Malaria in Melbourne 2021 (Oct 28-29) free registration is now open! Register now and submit your abstract at… https://t.co/W1ZzexS8cA

21 Jul 2021

Why local expertise is key to PATH's new strategy https://t.co/RWWcHbRLgW

19 Jul 2021

RT @NoorAbdisalan: The WHO-GMP is setting up a Malaria Strategic Information Technical Advisory Group to advise on technical and opera… https://t.co/uLA4fCDe5Y

16 Jul 2021

RT @MalariaWorld: Job opportunity at Imperial College London - Target Malaria Impact Assessment Officer. Closing date: 18 August 2021… https://t.co/OC0CWeLrwK

14 Jul 2021

RT @malarianomoreuk: To #endmalaria, we need to stay one step ahead of the parasite - that means well-funded science and innovation is k… https://t.co/NmSeogccE0

8 Jul 2021

PATH is #hiring for a senior-level #vaccine immunologist position. Lead our work to identify correlates of protecti… https://t.co/YIpwgreWKZ

1 Jul 2021

Happening today -- a conversation with Dr. Ashley Birkett and John Bawa of @MalariaVaccine. Please register at this… https://t.co/0V2sCaLUHU

30 Jun 2021

RT @PATHtweets: Today, we are announcing the launch of a new five-year organizational strategy. The strategy’s three priorities,… https://t.co/ELGM1VeMmT

29 Jun 2021

RT @PMIgov: We were created to give children in malaria-endemic countries a healthy childhood. We've made great progress, but w… https://t.co/ouGU4l0xox

23 Jun 2021